ZAGG (ZAGG) (DDD) (MT) (BAC) (BAX) (BIG) Ratings Reiterated

ZAGG (NASDAQ:ZAGG), 3D Systems (NYSE:DDD), Arcelor Mittal (NYSE:MT), Bank of America (NYSE:BAC), Baxter (NYSE:BAX) and Big Lots (NYSE:BIG) had rating on them reiterated by analysts.

Northland Securities reiterated its rating on ZAGG (ZAGG). They have an "Outperform" rating on the company, and raised its price target from $20 to $22.

Barclays Capital reiterated its rating on 3D Systems (DDD). They have an "Equal Weight" rating on the company, and cut its price target from $23 to $19.

Deutsche Bank (NYSE:DB) reiterated its rating on Arcelor Mittal (MT). They have a "Hold" rating on the company, and slashed their price target on them from $38.50 to $24.50.

RBC Capital Markets reiterated its rating on Bank of America (NYSE:BAC). They have an "Outperform" rating on the company, and lowered their price target from $12 to $10.

Ticonderoga reiterated its rating on Baxter (NYSE:BAX). They have a "Buy" rating on the company, and raised their price target from $60 to $62.

ZAGG (ZAGG) (BAC) (YHOO) (BAX) (MDCO) (BIG) Price Targets Changed

ZAGG (NASDAQ: ZAGG), Bank of America (NYSE: BAC), Yahoo! Inc. (NASDAQ: YHOO), Baxter International Inc. (NYSE: BAX), The Medicines Company (NASDAQ: MDCO) and Big Lots, Inc. (NYSE: BIG) price targets adjusted by analysts.

ZAGG (ZAGG) had its price target raised by Northland Securities from $20.00 to $22.00. They have an “Outperform” rating on the company.

Bank of America (BAC) had its price target lowered by RBC Capital from $12.00 to $10.00. They have an “Outperform” rating on the company.

Yahoo! Inc. (YHOO) had its price target lowered by UBS AG (NYSE:UBS) to $14.75. They have a “Neutral” rating on the company.

Baxter International Inc. (BAX) had its price target raised by Ticonderoga from $60.00 to $62.00. They have a “Buy” rating on the company.

The Medicines Company (MDCO) had its price target lowered by Argus from $25.00 to $20.00. They have a “Buy” rating on the company.

Big Lots, Inc. (BIG) had its price target raised by Wedbush from $32.00 to $34.00. They have a “Neutral” rating on the company.